Debt to EBITDA ratio Analysis of Vaishali Pharma Ltd. - Deep Dive
Birds's Eye
Fundamentals
Fundamentals
Technicals
MovingAverage
Candlestick
PivotPoint
Beta&Vols
Tech ChartsDebt to EBITDA of VAISHALI
Mar-253.61Indecisive Debt to EBITDA | Mar-244.17Not Good Debt to EBITDA | Growth-13.51% |
Debt to EBITDA Analysis of Vaishali Pharma Ltd.
| Debt to EBITDA Ratio of VAISHALI has fallen by -13.51 % Compared to previous Financial Year. |
| Debt to EBITDA Ratio with value of 4.17 was highest in Year Mar-24 in last Five Years. |
| Debt to EBITDA Ratio with value of 1.20 was lowest in Year Mar-23 in last Five Years. |
| Latest Debt to EBITDA Ratio with value of 3.61 is Greater than Average Debt to EBITDA of 3.06 in last five years. |
Other Debt to EBITDA Related Info of VAISHALI that may interest you.
Vaishali Pharma Ltd. Overview
| Code | Price | Previous Price | Price Change | Sector |
|---|---|---|---|---|
| VAISHALI | 10.04 | 10.07 | 0.298 % | Drugs & Pharma |
Defination of Debt to EBITDA
The Debt to EBITDA Ratio is a solvency metric that measures the company's ability to meet its debt obligations by earnings before covering its interest, taxes, depreciation, and amortization. more ..
Debt to EBITDA Related Ratios
| CashFlowFromOperationToDebt | DebtToCapital | EVToEBITDA |
Tsr Stability Index
| No Significant Stability | Screener |
FY - Historical Debt to EBITDA of Vaishali Pharma Ltd.
| Period | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 |
|---|---|---|---|---|---|---|---|
| Debt to EBITDA | 3.61 | 4.17 | 1.20 | 2.29 | 4.02 | 5.10 | 4.02 |
| Change | -13.51 % | 246.24 % | -47.41 % | -43.05 % | -21.17 % | 26.93 % | 576.32 % |
| Price | 12.58 | 14.01 | 14.59 | 6.62 | 3.26 | 4.00 | 4.35 |
| Price Change | -10.17 % | -4.01 % | 120.56 % | 102.91 % | -18.60 % | -7.93 % | -28.86 % |